William Krivit
About
In The Last Decade
William Krivit
267 papers receiving 13.4k citations
Hit Papers
Peers
Comparison fields: 5 of 153
- Hematology 4.2k
- Physiology 4.1k
- Molecular Biology 3.6k
- Genetics 2.4k
- Epidemiology 2.1k
Countries citing papers authored by William Krivit
This map shows the geographic impact of William Krivit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Krivit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Krivit more than expected).
Fields of papers citing papers by William Krivit
This network shows the impact of papers produced by William Krivit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Krivit. The network helps show where William Krivit may publish in the future.
Co-authorship network of co-authors of William Krivit
This figure shows the co-authorship network connecting the top 25 collaborators of William Krivit. A scholar is included among the top collaborators of William Krivit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Krivit. William Krivit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 329 | |
| 2 | Survival in Hurler's disease following bone marrow transplantation in 84 patients | 14 |
| 3 | 15 | |
| 4 | 7 | |
| 5 | Phase II trial of poly(I,C)-LC, an interferon inducer, in the treatment of children with acute leukemia and neuroblastoma: a report from the Children's Cancer Study Group. | 15 |
| 6 | Phase II trial of a complex polyriboinosinic-polyribocytidylic acid with poly-L-lysine and carboxymethyl cellulose in the treatment of children with acute leukemia and neuroblastoma: a report from the Children's Cancer Study Group. | 43 |
| 7 | 80 | |
| 8 | 80 | |
| 9 | Selective deficiency in collagen-induced platelet aggregation during L-asparaginase therapy. | 14 |
| 10 | Pharmacokinetics of vincristine and cis-platinum in an anephric patient with metastatic Wilm's tumor | 1 |
| 11 | 23 | |
| 12 | Phase II study of cis-dichlorodiammineplatinum(II) in childhood osteosarcoma: Children's Cancer Study Group Report. | 31 |
| 13 | 20 | |
| 14 | Intravenous injection of purified hexosaminidase A into a patient with Tay-Sachs disease. | 55 |
| 15 | 11 | |
| 16 | 41 | |
| 17 | 5 | |
| 18 | 74 | |
| 19 | 3 | |
| 20 | 8 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.